Celularity Inc.

NASDAQ: CELUW · Real-Time Price · USD
0.06
0.00 (0.00%)
At close: May 23, 2025, 2:23 PM

Celularity Statistics

Share Statistics

Celularity has 23.95M shares outstanding. The number of shares has increased by -79.94% in one year.

Shares Outstanding 23.95M
Shares Change (YoY) -79.94%
Shares Change (QoQ) -64.85%
Owned by Institutions (%) 0.01%
Shares Floating n/a
Failed to Deliver (FTD) Shares 122
FTD / Avg. Volume 0.59%

Short Selling Information

The latest short interest is 84.84K, so 0% of the outstanding shares have been sold short.

Short Interest 84.84K
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 9.81

Valuation Ratios

The PE ratio is -0.79 and the forward PE ratio is null. Celularity's PEG ratio is 0.01.

PE Ratio -0.79
Forward PE n/a
PS Ratio 0.84
Forward PS n/a
PB Ratio 5.15
P/FCF Ratio -6.94
PEG Ratio 0.01
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Celularity.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.38, with a Debt / Equity ratio of 3.29.

Current Ratio 0.38
Quick Ratio 0.28
Debt / Equity 3.29
Debt / EBITDA -0.76
Debt / FCF -4.42
Interest Coverage 6.12

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $451,833.33
Profits Per Employee $-482,433.33
Employee Count 120
Asset Turnover 0.41
Inventory Turnover 1.64

Taxes

Income Tax n/a
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by 150% in the last 52 weeks. The beta is 0.61, so Celularity's price volatility has been higher than the market average.

Beta 0.61
52-Week Price Change 150%
50-Day Moving Average 0.05
200-Day Moving Average 0.03
Relative Strength Index (RSI) 47.89
Average Volume (20 Days) 20,624

Income Statement

In the last 12 months, Celularity had revenue of 54.22M and earned -57.89M in profits. Earnings per share was -2.64.

Revenue 54.22M
Gross Profit 45.33M
Operating Income -38.36M
Net Income -57.89M
EBITDA -38.36M
EBIT n/a
Earnings Per Share (EPS) -2.64
Full Income Statement

Balance Sheet

The company has 738K in cash and 29.03M in debt, giving a net cash position of -28.3M.

Cash & Cash Equivalents 738K
Total Debt 29.03M
Net Cash -28.3M
Retained Earnings -899.68M
Total Assets 132.68M
Working Capital -33.12M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.4M and capital expenditures -161K, giving a free cash flow of -6.56M.

Operating Cash Flow -6.4M
Capital Expenditures -161K
Free Cash Flow -6.56M
FCF Per Share -0.3
Full Cash Flow Statement

Margins

Gross margin is 83.6%, with operating and profit margins of -70.75% and -106.77%.

Gross Margin 83.6%
Operating Margin -70.75%
Pretax Margin -106.77%
Profit Margin -106.77%
EBITDA Margin -70.75%
EBIT Margin -70.75%
FCF Margin -12.1%

Dividends & Yields

CELUW does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for CELUW.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Scores

Altman Z-Score -10.43
Piotroski F-Score 5